共 268 条
[21]
Patel CG(2020)Meta-analysis of the associations of CYP2B6-516G>T polymorphisms with efavirenz-induced central nervous system side effects and virological outcome in HIV-infected adults Pharmacogenomics J 20 246-102
[22]
Ogasawara K(2021)Meta-analysis of ABCG2 and ABCB1 polymorphisms with sunitinib-induced toxicity and efficacy in renal cell carcinoma Front Pharmacol 12 97-2781
[23]
Akhlaghi F(2018)Polymorphisms in IMPDH2, UGT2B7, and CES2 genes influence the risk of graft rejection in kidney transplant recipients taking mycophenolate mofetil Mutat Res, Genet Toxicol Environ Mutagen 836 2678-543
[24]
Westley IS(2014)Correlation of inosine monophosphate dehydrogenase gene polymorphisms and acute rejection in renal transplantation Chin J Exp Surg 31 537-1713
[25]
Brogan LR(2010)Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil Pharmacogenet Genomics 20 1703-73
[26]
Morris RG(2010)SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients Pharmacogenomics 11 69-327
[27]
Evans AM(2011)Association of UDP-glucuronosyltransferase 1A9 (UGT1A9) gene polymorphism with kidney allograft function Ann Transplant 16 319-491
[28]
Sallustio BC(2009)UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients Clin Pharmacol Ther 86 486-76
[29]
Picard N(2012)Inosine monophosphate dehydrogenase polymorphisms and renal allograft outcome Transplantation 94 70-1598
[30]
Bergan S(2010)An inosine 5′-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid Pharmacogenomics J 10 1584-1302